Go to the page content

GLP-1 treatment and how it works

Glucagon-like peptide 1 (GLP-1) is a naturally occurring hormone in the body that has a number of benefits, particularly for people with type 2 diabetes1.  

Therefore, GLP-1 RA (receptor agonist) treatments have been developed to mimic the function of the GLP-1 hormone and increase its effect as it occurs in people without type 2 diabetes1, 2. 

GLP-1 RA is a class of non-insulin medication that assists your body’s natural ability to regulate blood sugar and appetite2.

Body

How does GLP-1 work?

Liver

Liver and pancreas

GLP-1 RA helps maintain normal blood glucose levels by telling your pancreas when to release more insulin when needed2.
At the same time, it also suppresses the release of stored sugar from your liver2.
Brain

Brain

GLP-1 RA helps support weight loss by working in the part of your brain that regulates your appetite and food intake1, 2.
Balance

Balance

It’s all about balance!
By getting your blood glucose and weight under control early, you greatly reduce your risk of future complications such as heart failure6.
However, even if you suffer a heart attack or stroke, there are treatments that can help reduce the risk of subsequent cardiovascular events3,6.
Doctor
Want to know more?
Ask your doctor if a GLP-1 RA is right for you.

Are you ready to test your knowledge?

Take the quiz to find out how much you know about type 2 diabetes and GLP-1 RAs.

 

Question 1 of 6

Busting Diabetes Myths

Millions of people are living with diabetes, approximately 90% of whom suffer from type 2 diabetes7. Despite its prevalence, many myths still persist. At Novo Nordisk, we're committed to improving awareness and treatment for everyone at risk of diabetes across the globe.

 

Myth #1

Blood sugar is the only important factor when it comes to managing diabetes.

It is also important to manage weight, diet and exercise

Myth #2

Type 2 diabetes can be cured with lifestyle therapy alone.

As a progressive disease, medication is often required.

Myth #3

Treatments for type 2 diabetes only target blood sugar.

Some treatments can also reduce the risk of heart disease<sup>3</sup>

Myth #4

People with type 2 diabetes are at higher risk of cardiovascular disease.

9 in 10 people with type 2 diabetes face higher risk.

Myth #5

Insulin therapy is the only viable option for type 2 diabetics.

Insulin is just one of many types of diabetes treatments.

Myth #6

The human body has a naturally occurring hormone called GLP-1 that helps manage blood sugar and regulate appetite.

GLP-1 is a naturally occurring hormone that manages blood sugar and regulates appetite.

Bad Luck

You learn more from defeat than victory! Better luck next time.

Good Work

Not bad at all! Still some room for improvement.

Excellent

You're an expert mythbuster! Time to challenge your friends.

Blood sugar is the only important factor when it comes to managing diabetes.

Correct

While blood sugar is a key part of diabetes management, there are a number of risk factors that influence your long-term health, including weight, diet, and exercise. Staying in control help reduce your risk of cardiovascular events such as heart attacks and strokes.



Learn more about monitoring blood sugar
Type 2 diabetes can be cured with lifestyle therapy alone.

Correct

Type 2 diabetes is a progressive disease, meaning your condition will evolve over time. And faster if left untreated. While diet and exercise can help stabilise your condition, at some stage, diabetes will require prescribed medication to help balance your metabolism and blood sugar<sup>7</sup>.



Learn more about balancing lifestyle factors and medication
Treatments for type 2 diabetes only target blood sugar.

Correct

Balancing blood glucose is important as type 2 diabetes impairs the body's natural ability to produce insulin. However, treatments should also address heightened risk factors like cardiovascular disease, the leading cause of death for people with type 2 diabetes.



Learn more about diabetes and heart disease
People with type 2 diabetes are at higher risk of cardiovascular disease.

Correct

People living with type 2 diabetes face higher risk of cardiovascular disease, even if symptoms aren't apparent. Ask your doctor about glucose-lowering, cardio-protective treatment options.



Learn more about cardiovascular risk
Insulin therapy is the only viable option for type 2 diabetics.

Correct

There are several non-insulin diabetes treatments available, such as Metformin, Sulfonylureas, SGLT-2 inhibitors, and GLP-1 receptor agonists. As diabetes progresses, it may be necessary to start on one treatment or a combination of two or more.



Learn more about non-insulin treatment options
The human body has a naturally occurring hormone called GLP-1 that helps manage blood sugar and regulate appetite.

Correct

GLP-1, or glucagon-like peptide-1, helps your body release its own insulin and is designed to respond when your blood sugar rises. It also slows down food leaving your stomach and helps reduce the amount of sugar released from your liver.



Learn more about GLP-1 and how it works

 

HQ21DI00124

References
  1. Kim W and Egan JM. The role of incretins in glucose homeostasis and diabetes treatment. Pharmacol Rev. 2008;60:470-512.
  2. Zhao X, Wang M, Wen Z, et al. GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects. Front Endocrinol (Lausanne). 2021;12:721135.
  3. Mannucci E, Dicembrini I, Nreu B, et al. Glucagon-like peptide-1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta-analysis and subgroup analysis of randomized controlled trials. Diabetes Obes Metab. 2020;22:203-211.
  4. Nahmias A, Stahel P, Xiao C, et al. Glycemia and Atherosclerotic Cardiovascular Disease: Exploring the Gap Between Risk Marker and Risk Factor. Front Cardiovasc Med. 2020;7:100.
  5. Libby P, Buring JE, Badimon L, et al. Atherosclerosis. Nat Rev Dis Primers. 2019;5:56.
  6. Committee ADAPP. 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2024. Diabetes Care. 2023;47:S179-S218. doi: 10.2337/dc24-S010
  7. International Diabetes Federation. IDF Diabetes Atlas (10th edition). Available at: https://diabetesatlas.org/ Last accessed: February 2024.
  8. Mosenzon O, Alguwaihes A, Leon JLA, Bayram F, Darmon P, Davis TME, Dieuzeide G, Eriksen KT, Hong T, Kaltoft MS, et al. CAPTURE: a multinational, cross-sectional study of cardiovascular disease prevalence in adults with type 2 diabetes across 13 countries. Cardiovasc Diabetol. 2021;20:154. 
  9. MacDonald PE, El-kholy W, Riedel MJ, et al. The Multiple Actions of GLP-1 on the Process of Glucose-Stimulated Insulin Secretion. Diabetes. 2002;51:S434-S442. doi: 10.2337/diabetes.51.2007.S434

Related articles

How to make a simple plan for managing type 2 diabetes
3 min. read

How to make a simple plan for managing type 2 diabetes

Being diagnosed with type 2 diabetes can feel like a setback. But identifying the problem brings you closer to the solution. Here are some tips to get started.

Understanding diabetes

Type 2 diabetes

Type 1 diabetes

Gestational diabetes

Diabetes in children

Diabetes symptoms

Cardiovascular disease

Living with diabetes

Diabetes diet

Diabetes and exercise

Diabetes recipes

Diabetes blood sugar levels

Digital health and diabetes management

Treatments of diabetes

Type 2 diabetes treatment

Type 1 diabetes treatment

Insulin treatment

Gestational diabetes treatment